In order for any drug to be approved by America’s Food and Drug Administration (FDA) only two randomly controlled trials showing drug superiority are required. Otto and Nierenberg (2002) found that despite the quantity of trials showing no significant improvements in symptoms, researchers can continue to alter remedy conditions and hypothesis and selectively choose the […]
From the category archives: